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The aim of this study was to identify publications in literature that investigated Homocys-
teine  (He) as a risk factor for CVD among children and adolescents. An active search for
information  in LILACS, IBECS, Science Direct, Medline and Cochrane Library databases was
conducted using the following combination of keywords “homocysteine”, “cardiovascular
diseases”,  “child” and “adolescent”. Fifteen articles were analyzed showing direct relation-
ship  with increasing age (8 studies) and male gender (10 studies), and an inverse relationship
with  serum vitamins B6, B12 and folate levels. Thus, the results suggest that more  research
must  be carried through in order to determine in a more coherent way the causes of the
hiperhomocisteinemia in the pediatric population, guiding for an adequate diet, rich in
nutrients  necessary to favor the metabolism of the He.
Homocisteína:  fator  de  risco  cardiovascular  em  crianc¸as  e  adolescentes?
Palavras-chave:
Homocisteína
Doenc¸as  cardiovasculares
r  e  s  u  m  o
O objetivo do estudo foi identiﬁcar na literatura publicac¸ões  que investigaram a Homocis-
teína  (He) como um fator de risco para doenc¸as  cardiovasculares na faixa etária de crianc¸as
e  adolescentes. Realizou-se uma busca ativa de informac¸ões  nas bases de dados LILACS
© 2012 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDCrianc¸as
Adolescentes
e  IBECS, Science Direct, Medline e Biblioteca Cochrane, utilizando-se a combinac¸ão  dos
descritores  “homocysteine”, “cardiovascular diseases”, “child” e “adolescent”. Foram anal-
isados 15 artigos, os quais apontaram relac¸ão  direta dos níveis de He com o sexo masculino
(10  estudos) e com o aumento da idade (8 estudos), e uma relac¸ão  inversa com os níveis
séricos  das vitaminas B6, B12 e folatos (10 estudos). Sugere-se que sejam realizadas mais Study conducted at Centro de Obesidade Infantil, Instituto de Saúde Elpídio de Almeida, Campina Grande, PB, Brazil.
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pesquisas a ﬁm de determinar de maneira mais coerente as causas da hiperhomocisteine-
mia  na populac¸ão  pediátrica, orientando para uma dieta adequada e rica em nutrientes
necessários para favorecer o metabolismo da He.
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ardiovascular diseases (CVD) are a major public health prob-
em  for being the leading cause of death and disability,
ffecting adults in full productive age, resulting in loss of
otential  years of life and producing high costs for the public
ealth  system.1
Some risk factors for the development of CVD are well
nown,  such as age, male gender, dyslipidemia, smoking,
ystemic hypertension, diabetes mellitus, obesity, seden-
ary  lifestyle and genetic factors or parental history of
therosclerotic diseases.2 Currently, high levels of plasma
omocysteine (hyperhomocysteinemia) have been associated
ith  increased cardiovascular mortality rates, especially in the
dult  population.3
The pathogenesis of the vascular lesion caused by hyper-
omocysteinemia (HHe) includes endothelial cell lesion,
ascular smooth muscle growth, increased platelet adhesive-
ess,  increased LDL-cholesterol oxidation with deposition on
he vascular wall and direct activation of the coagulation
ascade.4
In this context, interest in homocysteine (He) as a causal
isk  factor for CVD in childhood was  stimulated by the obser-
ation  that over 50% of children with genetic disorder of
omocysteinuria died prematurely from vascular diseases, as
ell as the fact of high levels of He being associated with
hysiologic and nutritional factors.5
Thus, to determine the prevalence of cardiovascular risk
actors  in early childhood should be a priority among preven-
ive  measures, because atherogenesis may  precede by many
ears  its clinical manifestations, such as acute myocardial
nfarction (AMI) and stroke.6 Therefore, this study is a system-
tic  literature review of publications that have investigated He
s a risk factor for CVD in the age group composed of children
nd  adolescents.
ethods
he study methodology was  the active search for information
n  LILACS and IBECS (Virtual Health Library), Science Direct,
edline  and Cochrane Library databases, using the follow-
ng  combination of keywords “homocysteine”, “cardiovascular
iseases”, “child” and “adolescent”. There was  a query to the
eCS  service (Keywords in Health Sciences) of the Virtual
ealth  Library for standardization of keywords used in the
earch.  Studies conducted in the last 15 years were  screened
from  1997 to 2011), in Brazil and abroad, without restriction
s  for the language of publications, in which the assessment
© 20f  plasma homocysteine concentrations was  an independent
ariable of interest in the analysis of risk for cardiovascular
iseases by restricting the age group of children and/or ado-
escents  (0-19 years).The inclusion criteria were: (1) only original studies, full
text  available online; (2) samples that included children
and  adolescents (0-19 years); (3) cross-sectional, case-control
and/or  cohort studies. Theses/dissertations, review articles,
meta-analyzes and experimental studies with animal mod-
els  were excluded. These criteria were  used to increase the
comparability of ﬁndings between studies.
Data were extracted independently by three of the authors.
Disagreements were resolved by consensus among authors.
The  ﬁrst screening was  performed including the following
combination of keywords “homocysteine” and “cardiovascular
diseases” and “child” and “homocysteine” and “cardiovascu-
lar  diseases” and “adolescent”, in which the authors sought to
identify abstracts in duplicate, delete references of abstracts
without  full article available, literature reviews and disser-
tations.  In a second step, only publications of studies that
investigated the topic of interest with samples composed of
children  and adolescents were selected. In the third step, the
references  of articles selected were  reviewed in order to cap-
ture  manuscripts not found in the search.
Results
A total of 678 studies were identiﬁed and obtained by the
ﬁrst  screening. In the previous analysis, 663 studies were
excluded  (Fig. 1). After the other two steps of the search
strategy adopted, 15 studies were selected, which met  the
pre-established inclusion and exclusion criteria, and, upon
completing  their reading, all were included in the ﬁnal sample
of  this study.
Table 1 shows the characterization of articles according to
the  ﬁrst author’s name, country where the study was  con-
ducted,  publication year, journal name, study type, sample,
objectives and main results.
All  studies showed He as a dependent variable, whose
plasma concentration was  compared to folate, vitamin B12
and  cobalamin concentrations, and to lipid and glucose pro-
ﬁles,  as well as to other demographic and clinical variables
and  those related to lifestyle (age, gender, BMI, blood pressure,
genetic  polymorphism and parental history of CVD).
In  most studies, boys had total He values higher than
girls8–11,15–17,19–21 with mean values of He  for boys ranging
from 5.22-13.30 mol/L, and for girls from 4.84-10.4 mol/L.
Nevertheless, in only one study, no differences were  observed
between  genders in relation to He concentrations.18
It is noteworthy that three studies found a strong rela-
tionship between serum He levels and parental history of
CVD.7,12,13 It is also interesting that eight studies showed a
directly  proportional relationship between increased He lev-
9,11,14,16–18,20,21
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDels  and increasing age. Eight studies evaluated
the association between He and serum folate and vitamin B12
concentrations.9,10,13,15,17,18,20,21 Only one study evaluated the
relationship between He levels and genetic polymorphisms.18
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Table 1 – Characteristics of screened studies.
Study/country/
publication year
Journal Design Sample Objective(s) Main results
Greenlund KJ/United
States/19997
Circulation
Journal
Cross-sectional 1,137 children
and  adolescents
(5-17 years)
To  examine the plasma He levels and its
association with parental history of CVD.
Elevated He levels have been observed in
children with positive parental history of CVD
Osganian SK/United
States/19998
JAMA Cross-sectional 3,524 adolescents
(13-14 years)
To  describe the distribution of serum He
concentrations among students.
The  average He concentration was signiﬁcantly
higher for boys;
Serum  He was not signiﬁcantly associated with
serum lipids or parental history of CVD;
De Laet C/United
States/19999
American
Journal of
Clinical Nutrition
Cross-sectional  647 children and
adolescents (5-19
years)
To  establish the He distribution in a total
population of healthy students and determine
the relationship between He, folate and vitamin
B12.
He concentrations were lower in children and
increased proportionally with age;
In adolescents aged 15 years, He concentrations
were higher in boys;
Shen
MH/Taiwan/200210
Clinical
Biochemistry
Cross-sectional  1,235 adolescents
(12-15 years)
To  examine the association between plasma He
levels, folate and vitamin B12, and cardiovascular
risk factors among children in Taiwan.
Boys  had higher plasma He levels than girls;
Plasma He levels were positively associated with
body weight and height and to systolic and
diastolic blood pressure, but not related to lipid
proﬁle;
Must A/United
States/200311
The Journal of
Nutrition
Cross-sectional  2,027 children
and  adolescents
(4-19 years)
To  describe the total He distribution in a sample
of children and adolescents in the U.S., and
assess the different He concentrations between
gender, age and ethnic categories.
The  total He concentrations for boys and girls
began to diverge at the age of 10 years and
increased in adolescence, and boys showed
higher concentrations; − Differences in total He
concentrations between ethnic categories were
found in the group of girls and were higher in
non-Hispanic African American girls;
Gillium RF/United
States/200412
Annals of
Epidemiology
Cross-sectional  941 adolescents
(12-16 years)
To  describe the distribution and assess the
association between total He concentration and
variables associated with the syndrome of
insulin resistance in adolescents.
There  was association between total He and
parental history of stroke and high blood
pressure or systolic blood pressure in male
adolescents; − There was no signiﬁcant
association  between total He and the percentage
of glycated hemoglobin A1c in boys and girls;
Casanueva
V/Chile/200313
Revista Médica
del  Chile
Case-Control  80 children and
adolescents
(6-15  years)
To  measure serum He, folic acid and vitamin B12
levels in children with and without parental
history of CVD.
Children  with parental history of CVD had higher
serum He levels than those without such history;
Beynum
IM/Holland/200514
American
Journal of
Clinical Nutrition
Cross-sectional  234 children and
adolescents (0-19
years)
To  describe total He and its predictors in Dutch
children.
In both sexes, total He concentrations increased
with age; − Plasma folate was considered a
dependent predictor of total He
Brasileiro
RS/Brazil/200515
Nutrición
Hospitalaria
Case-Control  239 adolescents
(15-19 years)
To  test the hypothesis that overweight
adolescents  had higher total He concentrations
than adolescents with normal weight and
explore the association between plasma He
levels with folic acid, vitamin B12 and some risk
factors for CVD in both groups.
The  averages of total He were elevated in both
groups and were higher in boys than in girls; −
Triglyceride, LDL cholesterol and insulin
resistance were  higher in overweight
adolescents,  and HDL cholesterol was higher in
the group with normal weight;
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Study/country/
publication year
Journal Design Sample Objective(s) Main results
Papandreou
D/Greece/200616
Clinical Nutrition Cross-sectional 524 children and
adolescents (6-15
years)
To investigate the distribution and determinants
of total serum He levels in healthy Greek
children.
Homocysteine levels were increasing with age
and boys showed total He levels higher than
girls; − Age and folate levels were the most
signiﬁcant and independent determinants
associated  with total He;
Papandreou
D/Greece/200617
British Journal of
Nutrition
Cross-sectional 520 children and
adolescents from
6-15  years of age
To provide a set of speciﬁc data for total He levels
and determine the relationship between He and
folic acid, vitamin B12, age, BMI, blood pressure
and diet in a Greek pediatric population.
The highest mean Hct concentration was found
in boys;
He concentrations were lower in children and
increased in proportion to age;
There was correlation between He levels and age,
serum folate, BMI and systolic blood pressure;
Huemer
M/Austria/200618
Pediatrics
Research
Cross-sectional 264 healthy
children and
adolescents aged
from  2-17 years
To investigate total He concentrations and the
relationship between He and folate, cobalamin,
genetic polymorphisms and other clinical
variables.
He concentrations were signiﬁcantly inﬂuenced
by age and folate and cobalamin concentrations;
− No differences were observed between
genders in relation to He concentrations;
Villarreal
E/Colombia/200819
Biomédica Cross-sectional 600 children aged
from 5-14 years
To determine the lipid proﬁle, He and PCR, and
identify the relationship between these markers
with gender, age and type of school.
The prevalence of high He levels was higher in
boys than in girls; − The prevalence of high
serum lipids was higher in girls than in boys;
Kerr
MA/England/200920
Pediatrics Cross-sectional 2,127 youth aged
from  4-18 years
To investigate age, gender, and lifestyle factors
as determinants of folate, vitamin B12 and He in
British children and adolescents and propose
reference ranges by age for these biomarkers.
He concentrations increased progressively with
age and were higher in boys than in girls;
Akanji
AO/Kuwait/201021
Nutrition,
Metabolism &
Cardiovascular
Diseases
Cross-sectional 774 healthy
adolescents (316
boys,  458 girls)
aged  from 10-19
years
To investigate age, gender and body mass as
determinants of folate, vitamin B12 and He
levels in Arab adolescents and propose reference
ranges by age and gender for these biomarkers.
There was a relationship between age and
increased He levels;
Boys  had signiﬁcantly higher total He levels;
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LILACS – 
4
IBECS - 
6
Science
Direct - 12 
Pubmed/Medline
- 656 
Cochrane
- 0 
678 abstracts identified in the databases
selected 
663 studies were excluded, namely:
1 disse rtation;
5 articles in duplicate;
320 abstracts without full text
available;
48 literature  revi ews;   
7 more articles obtained from
references were classified as
eligible articles   
1st step
8 studies  fo r  the 3rd  step:
review of  refe rences  
15 studies  selected  
304 articles were excluded
(they did not investigate the
subject of interest and were
focused on dietary
supplementation orgenetics)    
 2ndstep: Reading of titles and
abstracts 
stratFig. 1 – Search 
Discussion
The aim of this study was  to make a literature review on the
relationship  between He and cardiovascular risk among chil-
dren  and adolescents. Epidemiological studies have shown
that  HHe is an important risk factor for the development
of vascular disease.22 Noteworthy is the fact that 30-35% of
individuals  with CVD present normocolesterolemia, but more
than  40% of patients with primary disease of the coronary
artery, cerebrovascular or peripheral vascular have Hhe.23
Nevertheless, none of the articles evaluated pointed He as
an  independent cardiovascular risk factor in children and ado-
lescents.  The interest in He as a causal factor began from the
observation  that over 50% of children with genetic disorder of
homocysteinuria died prematurely from vascular diseases.24
The study by Huemer et al.18 found a signiﬁcant association
in  subjects who had high He concentrations and the MTHFR
677T  allele. In adults, genotypes MTHFR 677T and heterozy-
gous  MTHFR 677T/1298C are associated with HHe and CVD.25In addition to genetic disorders, folate and vitamin
B12 levels are inversely related to plasma homocysteine
concentration.26. Intracellular He metabolism occurs throughegy ﬂowchart.
two-way  remethylation, which is responsible for the conver-
sion  of He into methionine, and a one-way transsulfuration,
which converts He into cysteine. In the remethylation process,
folate  and vitamin B12 act as coenzymes, or co-substrates,
and in the transsulfuration process, in turn, vitamin B6 act as
coenzyme.2,27 Accordingly, the studies included in this review
assessed  He and these substrates, and found an inverse rela-
tionship.
Data  of this review are in agreement with literature, since
He  levels were  higher in males. The cause for the higher He
levels  in males may  be related to different rates of formation of
this  amino acid associated with increased creatine synthesis
and  increased muscle mass found in men. Assessing the dif-
ferences  in the methionine cycle with stable isotopes in men
and  women, Fukagawa et al.28 observed that the transmethy-
lation and remethylation rates of homocysteine were  higher
in  women  than in men. The authors suggested that the differ-
ence  between men  and women  regarding the need and use of
certain  amino acids would be responsible for the increased
remethylation rate observed in women. It is also possible
that  estrogens would provide reduced homocysteine levels;
however,  the mechanisms by which estrogen would cause a
reduction in homocysteine levels are still unknown.29,30
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Eight of the 15 studies analyzed showed that the He lev-
ls  in adolescents (aged over 10 years) were  higher than in
hildren.  Homocysteine levels increase with age, regardless
f  gender. This is secondary to the decreased levels of vita-
in  cofactors, resulting in reduced enzymatic activity in the
etabolic  pathway or to the coexistence of renal disease.31
n 1998, the study by Bydlowski et al.32 reported that children
end  to have lower He levels, and these levels tend to increase
ith  age. The decrease in production or in enzymatic activ-
ty  for the He metabolism, renal dysfunction, or decreased
ioavailability of vitamins (B6, B12 and folate), may  explain
his  phenomenon.27
In this review, three studies have evaluated the associ-
tion  between He and a positive parental history for CVD,
hich  emphasized the history of stroke and high systolic
nd/or  diastolic blood pressure. This is alarming, considering
he  strong relationship between He and atherogenic mech-
nisms,  since in all the articles analyzed, He was  identiﬁed
s  an independent risk factor for cardiovascular diseases,
egardless of age group in the three continents covered by
he  studies (America, Europe and Asia). A systematic review
ith  meta-analysis on He and cardiovascular risk developed
y  Humphrey et al.24 concluded that high He levels may  inde-
endently  and moderately increase by about 20% the risks of
eveloping  CVD. In addition, other studies, also using meta-
nalysis  techniques, assessed the beneﬁts of reducing serum
e  concentrations and found that the decrease of 3-5 mol/L
n  serum He levels can reduce the incidence of deep vein
hrombosis and stroke.33,34
Thus, the study by Brasileiro et al.15 stands out, whose
ample consisted of adolescents with and without excess
eight  and whose results showed higher He levels in the
verweight ones. Therefore, it could be inferred that, despite
he  pathophysiological mechanisms by which HHe can pro-
ote  atherothrombosis are not well deﬁned, vascular lesion
eﬁned  by the action of He includes endothelial cell lesion,
ascular  smooth muscle growth, increased oxidation of LDL
holesterol  with direct deposition on the vascular wall and
ncreased  platelet adhesiveness, phenomena also observed in
verweight individuals.35,36
On the other hand, the ﬁndings of this review indicate
he need for further studies, correlating He with other vari-
bles  such as renal function and insulin resistance. Only one
rticle  proposed assessing the relationship between He and
lycated  hemoglobin A1c levels; however, it found no sig-
iﬁcant  association. Nevertheless, it would be necessary to
nvestigate  insulin levels which have an inverse relationship
ith  He levels, since insulin contributes to decrease the serum
e  levels because it stimulates the biosynthesis of the hepatic
ystathionine -synthase enzyme, which is responsible for
e  degradation in the transsulfuration pathway.37 Finally, it
s  also important to evaluate the renal function, since kid-
eys  contain signiﬁcant amounts of enzymes involved in the
ranssulfuration and remethylation process, playing an impor-
ant  role in He metabolism and clearance.38onclusions
he results of the reviewed articles were quite homogeneous,
mphasizing the relationship between high He levels and
11 3;5  9(6):622–628  627
increased age and male gender. However, high levels of He
were  not related to the determination of cardiovascular risk
in  this population at none of the studies evaluated. Thus, the
results  of this review suggest that further studies should be
conducted,  especially in Brazil, since it has high morbidity and
mortality  rates from cardiovascular causes, especially case-
control  or cohort studies on the issue proposed, in order to
more  accurately determine the causes of HHe in the pediatric
population.
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